Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
BANB:SWX
BACHEM HOLDING AG
CHF 67.65
-1.46%
(-1.00) 1D
Apr 23, 5:30:19 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for BANB...
Open
CHF 68.00
High
CHF 68.90
Low
CHF 66.80
Mkt. cap
5.07B
Avg. vol.
151.49K
Volume
78.22K
Dividend
1.33%
Quarterly dividend
CHF 0.22
Ex dividend date
May 4, 2026
P/E ratio
34.08
52-wk high
CHF 76.00
52-wk low
CHF 46.16
EPS
CHF 1.98
Shares outstanding
75.00M
No. of employees
2K
News stories
From sources across the web
Profile
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacture of peptides and complex organic molecules for use as active pharmaceutical ingredients. The company focuses on peptide-based therapeutics, including large-scale commercial production and process development for pharmaceutical applications. It was founded in 1971 and is a subsidiary of Ingro Finanz AG. The head office is in Bubendorf in the canton of Basel-Landschaft. Bachem operates production facilities in Vionnaz, Vista and Torrance, and St Helens, as well as a sales and distribution site in Tokyo. Bachem is one of the largest manufacturers of peptide-based APIs globally, supplying pharmaceutical and biotechnology companies with products used in both clinical development and commercial therapies. In recent years, the company has expanded its manufacturing capacity, including new large-scale production facilities in Switzerland and the United States. At the end of 2025, the company employed 2,511 people, reported revenue of CHF 695.1 million, and net income of CHF 148.8 million. Wikipedia
About BACHEM HOLDING AG
CEOThomas Meier
Employees2.36K
Founded1971
Headquarters-
SectorHealth care
Websitebachem.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
156.49M
156.49M
191.04M
191.04M
Cost of goods sold
111.46M
111.46M
136.21M
136.21M
Cost of revenue
111.46M
111.46M
136.21M
136.21M
Research and development expenses
2.38M
2.38M
2.74M
2.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.45M
9.45M
10.16M
10.16M
Operating expense
11.57M
11.57M
4.65M
4.65M
Total operating expenses
123.03M
123.03M
140.85M
140.85M
Operating income
33.46M
33.46M
50.19M
50.19M
Other non operating income
-17.50K
-17.50K
-25.00K
-25.00K
EBT including unusual items
28.09M
28.09M
50.11M
50.11M
EBT excluding unusual items
28.09M
28.09M
50.11M
50.11M
Income tax expense
3.04M
3.04M
764.50K
764.50K
Effective tax rate
10.82%
10.82%
1.53%
1.53%
Other operating expenses
-258.50K
-258.50K
-8.25M
-8.25M
Net income
25.05M
25.05M
49.35M
49.35M
Net profit margin
16.01%
16.01%
25.83%
25.83%
Earnings per share
-
-
-
-
Interest and investment income
94.00K
94.00K
33.50K
33.50K
Interest expense
-61.00K
-61.00K
-138.00K
-138.00K
Net interest expenses
33.00K
33.00K
-104.50K
-104.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
41.55M
41.55M
63.83M
63.83M
Gain or loss from assets sale
24.00K
24.00K
-1.09M
-1.09M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer